Dyadic International, Inc.
Dyadic International, Inc.
Dyadic International, Inc.
DYAI
DYAI
Nasdaq
Health Services
Medical/Nursing Services
1.19
USD
-0.02
-1.65%
마감됨: 07-24 20:00 (UTC+0)
1.19
USD
+0.0559
+4.70%
장후: 07-25 00:00 (UTC+0)

DYAI 주요 통계

고가
1.26
개시가
1.21
거래량
105.18K
저가
1.12
전일 종가
1.21
거래대금
125.54K
52주 최고가
1.60
상대 거래량
0.371
변동폭 (%)
11.49%
52주 최저가
0.65
회전율
0.29%
시가총액
43.36M
PER (TTM)
--
PER (연간)
--
PBR
-106.35
PSR
11.39
주당순이익(EPS)
-0.214
배당금(TTM)
0
배당수익률
0.00%
발행주식수
36.43M
통화 단위
USD

DYAI 가격 수익률

7 일
30 일
90 일
180 일
연초 이후
1 년
DYAI 자금 흐름 분포
DYAI 일일 공매도 거래량
DYAI 공매도 잔고 내역
As of 2026-07-26, the Dyadic International, Inc. (DYAI) stock price today is 1.19. Based on this price, the company has a market capitalization of $43.36M, with a P/E ratio of --. On 2026-07-26, DYAI traded between 1.12 and 1.26. Today’s stock price is 6.25% above the daily low and 5.56% below the daily high, placing DYAI 중간 부근에 its most recent trading range. Trading volume currently stands at 105.18K, compared with an average daily volume of 283.91K. This suggests that trading activity is 평소 수준을 크게 밑도는 than usual. Over the past year, Dyadic International, Inc. shares have traded between 0.65 and 1.60. At today’s price, DYAI is 83.08% above its 52-week low and 25.63% below its 52-week high.
회사 이름
Dyadic International, Inc.
섹터
Health Services
산업
Medical/Nursing Services
거래소
Nasdaq
직원 수
5
랏 크기
100
공식 웹사이트
통화 단위
USD
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

DYAI FAQ

검색
더보기